Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Agbor-Enoh

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 4, 2021
Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injuryKatrina Bazemore, Michael Rohly, Nitipong Permpalung, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 31, 2026
Donor-derived cell-free DNA associated with increased risk of chronic lung allograft dysfunction and mortality: Are absolute levels better than percentage?Kellie Phipps, Hyesik Kong, Han Su, et al.
JCI Insight|March 2, 2021
Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injuryTemesgen E Andargie, Naoko Tsuji, Fayaz Seifuddin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 22, 2022
Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunctionKatrina Bazemore, Nitipong Permpalung, Joby Mathew, et al.
Transplantation Direct|July 2, 2024
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort StudyMichael B Keller, Junfeng Sun, Muhtadi Alnababteh, et al.
American Journal of Respiratory and Critical Care Medicine|January 8, 2024
Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical TrialMichael B Keller, Xin Tian, Moon Kyoo Jang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 2, 2023
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or deathMichael Keller, Song Yang, Lucia Ponor, et al.
Medrxiv : the Preprint Server for Health Sciences|June 26, 2025
Utility of Plasma Cell-free Chromatin Immunoprecipitation to Detect Cardiac Allograft RejectionMoon Kyoo Jang, Oladele Oluwayiose, Neelam Redekar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 19, 2025
Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantationAnanth V Charya, Moon K Jang, Hyesik Kong, et al.
Circulation. Heart Failure|January 12, 2026
Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAsJason F Goldberg, Pramita Bagchi, Angela Mercado, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 4, 2021
Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injuryKatrina Bazemore, Michael Rohly, Nitipong Permpalung, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 31, 2026
Donor-derived cell-free DNA associated with increased risk of chronic lung allograft dysfunction and mortality: Are absolute levels better than percentage?Kellie Phipps, Hyesik Kong, Han Su, et al.
JCI Insight|March 2, 2021
Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injuryTemesgen E Andargie, Naoko Tsuji, Fayaz Seifuddin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 22, 2022
Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunctionKatrina Bazemore, Nitipong Permpalung, Joby Mathew, et al.
Transplantation Direct|July 2, 2024
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort StudyMichael B Keller, Junfeng Sun, Muhtadi Alnababteh, et al.
American Journal of Respiratory and Critical Care Medicine|January 8, 2024
Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical TrialMichael B Keller, Xin Tian, Moon Kyoo Jang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 2, 2023
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or deathMichael Keller, Song Yang, Lucia Ponor, et al.
Medrxiv : the Preprint Server for Health Sciences|June 26, 2025
Utility of Plasma Cell-free Chromatin Immunoprecipitation to Detect Cardiac Allograft RejectionMoon Kyoo Jang, Oladele Oluwayiose, Neelam Redekar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 19, 2025
Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantationAnanth V Charya, Moon K Jang, Hyesik Kong, et al.
Circulation. Heart Failure|January 12, 2026
Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAsJason F Goldberg, Pramita Bagchi, Angela Mercado, et al.
Pageof 9